
Venture capital
OMX Ventures
OMX Ventures is a technology-focused venture firm that builds biotech companies from early scientific discoveries, operating across the Atlantic. Its portfolio covers therapeutics, biotools and diagnostics, and synthetic biology.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is OMX Ventures right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds OMX Ventures joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, OMX Ventures’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company OMX Ventures backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet OMX Ventures
Events where OMX Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
OMX Ventures is based in Lincolnshire, United States.
2 fund vehicles are on public registers (SEC adviser filings), including OMX VENTURES FUND I, LLC and OMX OPPORTUNITY FUND I, LLC.
Sectors: Biotech, Life sciences. From the firm’s own website.
OMX Ventures lists 29 portfolio companies on its website, including Delix, Freya, Constructive Bio, Matterworks and VedaBio.
Firms whose websites list some of the same companies include Artis, Foresite Capital and KdT Ventures.
Know before OMX Ventures’s next round is announced.
PRO tracks OMX Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.